2ND ANNUAL CANCER IMMUNOTHERAPY SUMMIT

    In this summit, the most successful and promising new cancer treatment strategies will be explored. This summit is one of the most important opportunities, where you will explore the best practices in cancer immunotherapy. It is particularly important for the fields key opinion leaders, most exciting newcomers and others to come together to discuss and learn about the up-to-the-minute trends.
    The summit ensures maximum knowledge transfer among professionals and decision makers to exchange and elaborate on the best practices and explore business partnership opportunities. This premier B2B summit is one of the few opportunities, where you will meet face to face with leading industry professionals and decision makers and discuss your business potential and opportunities. It will also enable the participants to learn about the most advanced techniques and tools through which they can assess their portfolios and development potential.

    KEY TOPICS

    EU and US Regulatory aspects

    Management of side effects

    What’s new in specific cancer types – News in specific cancer types

    The true potential of the next generation immune checkpoint pathways

    Resistance to therapy

    Patient selection and predictive biomarkers

    Advancements in T-cell engineering

    Commercialization of Viable T-cell therapies

    Revolutionary cancer treatment with personalised cancer vaccines

    Combining immune checkpoint inhibitors with chemotherapy or radiotherapy and beyond

    Technological developments

    Preclinical and clinical progress in Cancer Immunotherapy

    Advanced methods, technological developments and strategies in Cancer Immunotherapy

    Imaging and nuclear medicine and design of immuno-oncology trials

    Progressive genetic engineering techniques

    WHY YOU SHOULD BE HERE?

    Network with business development and licensing professionals as well as professionals in your sector

    Implement the latest innovations

    Learn about the latest technologies and most pressing topics specific to your business

    Get an overview on innovative emerging technologies and promote business partnerships within the sector

    Interact and connect with leading professionals

    Discuss about new opportunities for your products and services with key decision makers

    FEATURED SPEAKERS

    Ivan Diaz-Padilla, MD, PhD

    Senior Medical Director Oncology Global Development
    Novartis

    Louis Boon

    Chief Scientific Officer
    Bioceros

    Dr. John Maher

    Clinical Senior Lecturer/Honorary Consultant in Immunology
    Kings College London

    Dr. Marek Štastný, PhD.

    Senior Scientific Advisor Oncology/Immuno-oncology
    Bristol-Myers Squibb

    Stefanos Theoharis

    SVP Corporate Development and Partnering
    Cell Medica

    Larissa S. Carnevalli, PhD

    Associate Principal Scientist Oncology Disease Models and Mechanisms Group
    AstraZeneca

    Madalin Sevestrian

    Scientist
    PAREXEL

      Ronald Kurt Kuoch

      Biomarker & Diagnostics Biopharma Global Early Development
      Merck
        Close

        FEATURED COMPANIES

        MEDIA PARTNERS

        REQUEST FORM









        GREAT OFFERS, RIGHT IN YOUR INBOX!

        Subscribe to our newsletter and get up-to-date information regarding the ``Global Cancer Immunotherapy Summit``

        Events | Terms and Conditions | Privacy Policy | Cookies Policy | Careers

        Copyright 2018 © Sharonat Group s.r.o. All rights reserved.

        Send